Researchers at Rx Biosciences are constantly trying to identify genes involved in the onset and progression of prostate cancer and leukemia. Currently, Rx Biosciences has been funded by NCI to identify substrates for Pim-1 kinase of great clinical importance. The technology being developed by us will identify substrate phosphorylation in real-time.

Rx Biosciences is also developing technology to silence the gene of interest in a more controlled and guided manner. The technology is expected to be more efficient than siRNA based technologies.